Letter to the Editor
Published on 28 Apr 2025
Successful treatment of familial cases of epidermolysis bullosa pruriginosa with dupilumab
Journal of Cutaneous Immunology and Allergy
doi 10.3389/jcia.2025.14677
389 Publications
Volume 8 - 2025
Case Report
Published on 28 Apr 2025
Case Report: The relation between the incidence of disseminated intravascular coagulation in scrub typhus cases and its serotype in northeastern Japan
Journal of Cutaneous Immunology and Allergy
doi 10.3389/jcia.2025.14673
Letter to the Editor
Published on 08 Apr 2025
Diffuse large B-cell lymphoma misdiagnosed as cellulitis
Journal of Cutaneous Immunology and Allergy
doi 10.3389/jcia.2025.14541
Original Research
Published on 01 Apr 2025
Establishment of α-Gal-specific IgE cutoff value to prevent cetuximab-induced allergic reactions in potential α-Gal syndrome
Journal of Cutaneous Immunology and Allergy
doi 10.3389/jcia.2025.14348
Brief Research Report
Published on 26 Mar 2025
An allergic subtype of acquired idiopathic generalized anhidrosis resistant to steroid pulse therapy – a retrospective, single-center, cohort study
Journal of Cutaneous Immunology and Allergy
doi 10.3389/jcia.2025.14190
Letter to the Editor
Published on 13 Mar 2025
Generalized pustular psoriasis with breast cancer successfully treated with granulocyte and monocyte adsorptive aphaeresis and brodalumab
Journal of Cutaneous Immunology and Allergy
doi 10.3389/jcia.2025.14441
Brief Research Report
Published on 10 Feb 2025
Effect of icatibant on sweating-induced dermal pain
Journal of Cutaneous Immunology and Allergy
doi 10.3389/jcia.2025.14276
Case Report
Published on 31 Jan 2025
Case report: Atopic dermatitis-like skin manifestations in hypohidrotic ectodermal dysplasia caused by a novel splice site mutation of the EDA gene successfully treated with dupilumab
Journal of Cutaneous Immunology and Allergy
doi 10.3389/jcia.2025.13813
Letter to the Editor
Published on 24 Jan 2025
Successful treatment of pyoderma gangrenosum complicated by JAK2V617F mutation-positive myelofibrosis with adalimumab and systemic steroid
Journal of Cutaneous Immunology and Allergy
doi 10.3389/jcia.2025.14079
Volume 7 - 2024
Original Research
Published on 20 Jan 2025
Real-life effectiveness and safety of baricitinib in 17 Japanese patients with alopecia areata: a 60-week single center study
Journal of Cutaneous Immunology and Allergy
doi 10.3389/jcia.2024.13890
Letter to the Editor
Published on 06 Jan 2025
Toxic epidermal necrolysis induced by nivolumab therapy for unresectable intraperitoneal cancer
Journal of Cutaneous Immunology and Allergy
doi 10.3389/jcia.2024.14014
Case Report
Published on 06 Jan 2025
Case report: Generalized granuloma annulare successfully treated with baricitinib in two cases
Journal of Cutaneous Immunology and Allergy
doi 10.3389/jcia.2024.13892
Case Report
Published on 03 Jan 2025
Case report: Mucormycosis due to Rhizopus microsporus: an important reminder of opportunistic infections in immunocompromised acute myeloid leukemia
Journal of Cutaneous Immunology and Allergy
doi 10.3389/jcia.2024.13995
Letter to the Editor
Published on 27 Nov 2024
A case of erythema elevatum diutinum associated with immunoglobulin A vasculitis
Journal of Cutaneous Immunology and Allergy
doi 10.3389/jcia.2024.14007
Correction
Published on 27 Nov 2024
Corrigendum: Age and gender differences in skin characteristics: a study of 2543 Japanese individuals using advanced skin imaging techniques
Journal of Cutaneous Immunology and Allergy
doi 10.3389/jcia.2024.14043
Letter to the Editor
Published on 22 Nov 2024
Postoperative pyoderma gangrenosum in a patient undergoing long-term nivolumab therapy
Journal of Cutaneous Immunology and Allergy
doi 10.3389/jcia.2024.13751